Physician

Abraham Mittelman, MD

According to 2025 Medicare claims, Abraham Mittelman, MD (NPI: 1013980903) practices medical oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is WHITE PLAINS PHYSICIAN SERVICES PC (NPI: 1124502687; TIN: 815309615) and primary practice location at 10601-5000.

Mittelman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 717 traditional Medicare patients, billed 3,238 HCPCS/CPT codes, and received $163,055 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,583 prescription claims across 417 beneficiaries totaling $5,430,958 in drug costs, led by Revlimid (Lenalidomide). DME data shows 64 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $2,863,895 to $163,055. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,679,055 to $5,430,958. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $2,863,895 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,351,296 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,253,411 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,629,768 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,185,417 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $159,355 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $192,715 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $185,260 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $172,531 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $163,055 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015840255,085$2,863,895
2016900216,512$3,351,296
2017918242,264$3,253,411
2018908203,445$3,629,768
2019940106,366$2,185,417
20207943,418$159,355
20218143,609$192,715
20227723,329$185,260
20237493,340$172,531
20247173,238$163,055

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.7M$5.4M2015 Drug cost: $1,679,055 (USD; Tot_Drug_Cst)2016 Drug cost: $1,769,814 (USD; Tot_Drug_Cst)2017 Drug cost: $1,814,934 (USD; Tot_Drug_Cst)2018 Drug cost: $1,927,054 (USD; Tot_Drug_Cst)2019 Drug cost: $2,936,510 (USD; Tot_Drug_Cst)2020 Drug cost: $3,808,277 (USD; Tot_Drug_Cst)2021 Drug cost: $4,143,842 (USD; Tot_Drug_Cst)2022 Drug cost: $4,425,405 (USD; Tot_Drug_Cst)2023 Drug cost: $4,865,559 (USD; Tot_Drug_Cst)2024 Drug cost: $5,430,958 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154272,082$1,679,055
20164331,917$1,769,814
20174051,777$1,814,934
20183651,600$1,927,054
20194271,906$2,936,510
20204812,558$3,808,277
20214522,508$4,143,842
20224552,510$4,425,405
20234392,495$4,865,559
20244172,583$5,430,958

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$50K$100K2015 Medicare payment: $99,734 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $45,143 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $27,279 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $12,706 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $8,773 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $9,724 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,758 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,814 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $7,354 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,702 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201541163$99,734
201640118$45,143
201722121$27,279
2018N/R83$12,706
2019N/R70$8,773
2020N/R129$9,724
2021N/R54$3,758
2022N/R68$1,814
2023N/R15$7,354
2024N/R64$1,702

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more1616$162
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more86127$116
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6951,709$78
36415Insertion of needle into vein for collection of blood sample6621,375$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide371,036$670,046
PomalystPomalidomide29812$668,462
ImbruvicaIbrutinib401,120$628,610
CalquenceAcalabrutinib Maleate361,080$544,420
VerzenioAbemaciclib34924$493,711

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R27$1,119
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R24$433
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R13$150

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Abraham Mittelman, MD?

Tedicare shows public-source Medicare data for Abraham Mittelman, MD (NPI 1013980903), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Mittelman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abraham Mittelman, MD?

Abraham Mittelman, MD is linked to WHITE PLAINS PHYSICIAN SERVICES PC (billing NPI 1124502687) in the available physician profile data.

Does Abraham Mittelman, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.